1FW2 vs 6IB: Side-by-Side Comparison
Compare WUXI BIOLOGICS-00000083 (1FW2) and Innovent Biologics Inc (6IB) side by side: market cap EUR 15.30B vs EUR 14.31B, P/E 24.8 vs 137.5. Financials, growth and model signals on Bullrun.
| Metric | 1FW2 | 6IB |
|---|---|---|
| Company | WUXI BIOLOGICS-00000083 | Innovent Biologics Inc |
| Country / Exchange | China · F | China · F |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Market cap | EUR 15.30B | EUR 14.31B |
| P/E ratio | 24.8 | 137.5 |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (latest FY) | EUR 18.68B | EUR 13.04B |
| Revenue growth YoY | +9.6% | +38.4% |
| Net income | EUR 3.36B | EUR 813.57M |
| Gross margin | 41.0% | 86.5% |
| Diluted EPS | 0.78 | 0.47 |